Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

The Romans created a remarkably organized and well-structured society. A big part of that was writing; they wrote often, and ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Two AI models have achieved gold medal standard for the first time in a prestigious competition for young mathematicians – ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis.

A University of Warwick epigraphy expert has collaborated with Google DeepMind to evaluate "Aeneas," an AI model that ...

The "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. ... Murdoch says human clinical trials for Isomorphic’s AI-designed drugs are finally ...

Prescription drugs designed by AI could be in clinical trials within years, DeepMind's CEO predicted. Demis Hassabis said in an interview he'd be "disappointed" if it took more than a couple of years.

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...